The role of PSMA PET/CT imaging in identifying low-risk prostate cancer candidates for active surveillance after biopsy
Expert Review of Anticancer Therapy · 03.08.2026 · 26 (8) · 971-975
DOI: 10.1080/14737140.2026.2640232 ↗Kurz gefasst
Editorial in der Zeitschrift Expert Review of Anticancer Therapy, online erschienen am 05.03.2026. Verfasst von Levent Kabasakal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cerrahpasa Faculty of Medicine, Department of Nuclear Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cerrahpasa Faculty of Medicine, Department of Nuclear Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Department of Nuclear Medicine, Turkish Ministry of Health, Yozgat City Hospital, Yozgat, Turkey.
ORCID-Profile: Levent Kabasakal
Zitieren
APA
Kabasakal, L., & Kaya, G. (2026). The role of PSMA PET/CT imaging in identifying low-risk prostate cancer candidates for active surveillance after biopsy. Expert Review of Anticancer Therapy, 26(8), 971-975. https://doi.org/10.1080/14737140.2026.2640232
Vancouver
Kabasakal L, Kaya G. The role of PSMA PET/CT imaging in identifying low-risk prostate cancer candidates for active surveillance after biopsy. Expert Review of Anticancer Therapy. 2026;26(8):971-975. doi:10.1080/14737140.2026.2640232
BibTeX
@article{Kabasakal2026,
author = {Kabasakal, Levent and Kaya, Gürsan},
title = {The role of PSMA PET/CT imaging in identifying low-risk prostate cancer candidates for active surveillance after biopsy},
journal = {Expert Review of Anticancer Therapy},
year = {2026},
volume = {26},
number = {8},
pages = {971--975},
doi = {10.1080/14737140.2026.2640232}
}
EUVIMED